Drug & Diagnostic development

A new paradigm in drug and diagnostic development is emerging. Exciting scientific discoveries in genome biology and technology are paving the way to new product development and commercial opportunities for Rx, Dx and technology platform companies. Join us in San Francisco this August for IBC's all new Drug & Diagnostic Development event - featuring these 4 compelling conferences:
+ show speakers and program
Victor Velculescu, M.D., Ph.D., Johns Hopkins University School of Medicine Richard K. Wilson, Ph.D., Washington University Howard Scher, M.D., Memorial Sloan-Kettering Cancer Center Garry P. Nolan, Ph.D., Stanford School of Medicine Richard Klausner, M.D., The Column Group Elizabeth S. Mansfield, Ph.D., CDER,US FDA Carlo Croce, M.D., The Ohio State University

6 Aug - 8 Aug 2012

San Francisco
United States of America
meeting website